Integer Holdings shareholders voted to approve KKR's $5.7 billion all-cash acquisition, clearing the final regulatory hurdle for the medical device component manufacturer to leave public markets. The deal values Integer at approximately $137 per share, a 37 percent premium to the stock's price the day before KKR's approach became public in late January.
Integer manufactures components for cardiac rhythm management devices, neuromodulation systems, and portable medical technologies. The company generated $1.6 billion in revenue over the trailing twelve months, with 72 percent derived from contracts with the top three cardiac device manufacturers—Medtronic, Abbott, and Boston Scientific. KKR's offer represents 3.6 times trailing revenue and roughly 18 times forward EBITDA, a multiple that reflects Integer's position as a critical supplier in oligopolistic end markets where switching costs run into the tens of millions.
The transaction gives KKR control of facilities in Switzerland, Malaysia, and Mexico that produce battery modules, hermetic packaging, and micro-welded assemblies under multi-year supply agreements. Integer's Greatbatch Medical unit holds 412 active patents related to implantable power systems, many of which cover lithium-ion chemistries tailored for devices that must function continuously for seven to twelve years inside the human body. The company also operates a contract manufacturing division that assembles portable oxygen concentrators and insulin delivery systems for nine of the top fifteen diabetes management companies.
KKR's healthcare industrials team has deployed $11.2 billion across medical supply chain assets since 2019, including the $4.2 billion acquisition of Envision Healthcare's ambulatory surgery division and a $2.1 billion stake in specialty pharmaceutical distributor PharMerica. The Integer deal extends this pattern into the component layer, where margin expansion typically comes from renegotiating long-term contracts as device volumes grow and from consolidating production across lower-cost geographies. Integer's Malaysia campus already handles 63 percent of the company's high-volume assembly work, and operating margins there run 840 basis points higher than at U.S. facilities.
The shareholder vote clears the path for deal close, expected between March 18 and March 25 pending final antitrust sign-off from the European Commission. Integer will file delisting paperwork with the NYSE within 48 hours of close. Watch for KKR to announce a new CEO within 90 days—Integer's current chief executive has indicated he will step down post-transaction—and for early moves to shift Integer's orthopedic trauma components division, which generates $180 million in annual revenue but operates at half the margin of the cardiac business, into a separate portfolio company structure.
The deal is KKR's second-largest healthcare take-private since the $8.4 billion acquisition of Envision in 2018. Integer shares last traded at $136.80, three cents below the offer price, pricing in negligible break risk and a close within twenty days.
The takeaway
KKR pays 3.6x revenue for the cardiac device supply chain's critical battery and hermetic packaging tier, betting on contract repricing as volumes grow.
Editorial & Disclosure Notice: This article was written with artificial intelligence from public sources and is published without individual human review. Artificial intelligence and other digital tools are also used for research, analysis, editing, formatting, and production. Errors, omissions, outdated information, or inaccuracies may occur. References to companies, brands, products, services, organizations, or individuals are for informational and editorial purposes and do not imply endorsement, sponsorship, affiliation, partnership, or approval unless expressly stated. All trademarks and other intellectual property remain the property of their respective owners. Opinions, analysis, estimates, and commentary are informational only and should not be construed as financial, investment, legal, tax, medical, procurement, or other professional advice. Information may be corrected, clarified, or updated after publication. Corrections or removal requests: jenny@pops4.com.
Want the 60-second program for your specific event?
Enter your event and email — we build it and send the branded proposal before lunch. No obligation.
The branded-identity layer Chiefs of Staff and heritage CMOs route through — your name imprinted on real authorized stock, your pick of 200+ brands and 70,000 products, shipped from one accountable house. Nine editorial desks publish the intelligence those operators read before they sign.
200+authorized brands
70,000products · virtual proof on each
9 deskspublishing daily
1997one house, since
70,000 SKUs · virtual proof in 60 seconds · no platform fee · blind-shipped · ASI #217876
Your next customer won't visit your website. Their AI will.
AI assistants have quietly taken over the first step of buying — they answer from catalogs they can read and shortlist whoever can actually ship. Two questions now decide whether you exist to that buyer: can a machine read your catalog, and can you fulfill the order. Most brands fail one or both and never find out why the orders went elsewhere. The winners of this shift aren't the loudest. They're the most readable. Build for the machine that's about to do the shopping.
Built by the craft floor — apparel, media, packaging, and secure print.
This trade runs on hands, not desks. Imprint manufacturing & Komori heritage press through approved vendors · Canon high-speed secure-media operations is a craft floor — genuine Six Sigma discipline applied to ink, thread, foil, and registration, where a hundredth of an inch is the difference between a brand that reads serious and one that reads cheap. POPS4 is built by exactly those operators: independent, boots-on-the-ground engineers who carry their own book, read a client in microseconds, and put their name on every run. Beyond our own Virginia Beach floor, we work with a vetted network of craft manufacturers across the US — each meeting the highest excellence in QC standards in the industry, each a specialist in its own discipline — so apparel, hard-goods imprinting, media manufacturing, packaging, and secure printing all go to the bench built for them, coordinated from one accountable hub. Short-run from twenty-five units, volume to five hundred thousand. Two hundred authorized national brands, seventy thousand SKUs with virtual proofing on every one. Art archived for instant reorders. Net-thirty corporate terms, NDA-standard white-label — your name on the work, or none at all.
Strategy, positioning, identity, creative, and messaging — wired into an AI system that publishes and distributes on its own. Nine editorial desks generate the authority, the production house ships the physical proof, and the attribution layer tells you which post sold which SKU. What you get is an operating layer — content, catalog, and order path under one roof — that keeps working whether or not you are in the room. Built for principals who would rather own the machine than rent the agency.
Named-account programs — one desk, quiet delivery, NDA-standard.
One point of contact who already knows the file, so nothing restarts from zero between engagements. The work ships blind, under NDA, with your name on it or none at all. Built for single-family offices, heritage-house CMOs, sports-ownership groups, and the agencies that white-label our production. The relationship is the product; the merch is the proof of it.
SFO · Chief of Staff desk. Principal household, properties, aircraft, yacht, calendar, philanthropy — one file.
Shop seventy thousand products. Virtual proof on every one. 24/7.
Drop your logo on any product and see the virtual proof before asking. Quote routes direct to the desk. MCP catalog for AI agents. Celeste for the fast conversation. Full self-service checkout in development.